- Home
- / Keymed Biosciences
Keymed Biosciences
Stock Price
$42.8
2024-10-29
Market Capitalization
$11.4 B
2024-10-29
Revenue
¥716.3 M
FY, 2025
Keymed Biosciences Summary
Company Summary
- Overview
- Keymed Biosciences is a provider of unmet clinical needs. It offers CM310, CM326, CM338, CM313, CM355, etc.
- Type
- Public
- Status
- Active
- Website
- https://www.keymedbio.com/
- Cybersecurity rating
Table of Contents
Keymed Biosciences Financials
Summary Financials
- Revenue (FY, 2025)
- ¥716.3M
- Gross profit (FY, 2025)
- ¥687.9M
- Net income (FY, 2025)
- (¥522.6M)
- Cash (FY, 2025)
- ¥503.3M
- EBIT (FY, 2025)
- (¥573.8M)
- Enterprise value
- $11.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026